Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 72

    1.

    The Yin and Yang of CD4(+) regulatory T cells in autoimmunity and cancer.

    Galgani M, Di Giacomo A, Matarese G, La Cava A.

    Curr Med Chem. 2009;16(35):4626-31.PMID: 19903146 [PubMed - in process]Related articles

    2.

    Leptin signaling: A key pathway in immune responses.

    Procaccini C, Lourenco EV, Matarese G, La Cava A.

    Curr Signal Transduct Ther. 2009 Jan 1;4(1):22-30.PMID: 19774101 [PubMed]Related articlesFree article

    3.

    The busy life of regulatory T cells in systemic lupus erythematosus.

    La Cava A.

    Discov Med. 2009 Jun;8(40):13-17.PMID: 19772836 [PubMed - as supplied by publisher]Related articles

    4.

    Leptin in non-autoimmune inflammation.

    Cai C, Hahn BH, Matarese G, La Cava A.

    Inflamm Allergy Drug Targets. 2009 Sep;8(4):285-91.PMID: 19754412 [PubMed - in process]Related articles

    5.

    Leptin as clinical target.

    Cai C, Shi FD, Matarese G, La Cava A.

    Recent Pat Inflamm Allergy Drug Discov. 2009 Nov;3(3):160-6.PMID: 19594439 [PubMed - in process]Related articles

    6.

    Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.

    Iikuni N, Lourenço EV, Hahn BH, La Cava A.

    J Immunol. 2009 Aug 1;183(3):1518-22. Epub 2009 Jul 1.PMID: 19570829 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antibody-based therapies in systemic lupus erythematosus.

    Iikuni N, La Cava A.

    Mini Rev Med Chem. 2009 Jun;9(7):829-46. Review.PMID: 19519508 [PubMed - indexed for MEDLINE]Related articles

    8.

    Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.

    Lourenço EV, Procaccini C, Ferrera F, Iikuni N, Singh RP, Filaci G, Matarese G, Shi FD, Brahn E, Hahn BH, La Cava A.

    J Immunol. 2009 Jun 15;182(12):7415-21.PMID: 19494264 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mimicking self-antigens with synthetic peptides in systemic autoimmune rheumatic diseases.

    Cai C, La Cava A.

    Curr Clin Pharmacol. 2009 May;4(2):142-7. Review.PMID: 19442079 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cytokines in systemic lupus erythematosus.

    Lourenço EV, La Cava A.

    Curr Mol Med. 2009 Apr;9(3):242-54. Review.PMID: 19355907 [PubMed - indexed for MEDLINE]Related articles

    11.

    Immunotherapy with peptides in systemic lupus erythematosus.

    La Cava A.

    Curr Med Chem. 2009;16(12):1482-8. Review.PMID: 19355901 [PubMed - indexed for MEDLINE]Related articles

    12.

    Natural Tregs and autoimmunity.

    La Cava A.

    Front Biosci. 2009 Jan 1;14:333-43. Review.PMID: 19273070 [PubMed - indexed for MEDLINE]Related articles

    13.

    Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus.

    Iikuni N, Hahn BH, La Cava A.

    Expert Opin Biol Ther. 2009 Feb;9(2):201-6. Review.PMID: 19236250 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lupus and T cells.

    La Cava A.

    Lupus. 2009 Mar;18(3):196-201. Review.PMID: 19213856 [PubMed - indexed for MEDLINE]Related articles

    15.

    Gender-Based Differences in Leptinemia in Healthy Aging, Non-obese Individuals Associate with Increased Marker of Oxidative Stress.

    Agrawal A, Lourenço EV, Gupta S, La Cava A.

    Int J Clin Exp Med. 2008;1(4):305-9. Epub 2008 Aug 12.PMID: 19079674 [PubMed - in process]Related articlesFree article

    16.

    New therapies in SLE.

    Ferrera F, Filaci G, Rizzi M, Singh RP, Indiveri F, Hahn BH, La Cava A.

    Recent Pat Inflamm Allergy Drug Discov. 2008;2(1):11-23. Review.PMID: 19075989 [PubMed - indexed for MEDLINE]Related articles

    17.

    Tuning immune suppression in systemic autoimmunity with self-derived peptides.

    Singh RP, Hahn BH, La Cava A.

    Inflamm Allergy Drug Targets. 2008 Dec;7(4):253-9. Review.PMID: 19075790 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tregs are regulated by cytokines: implications for autoimmunity.

    La Cava A.

    Autoimmun Rev. 2008 Oct;8(1):83-7. Epub 2008 Sep 2. Review.PMID: 18771756 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.

    Hahn BH, Anderson M, Le E, La Cava A.

    Arthritis Rheum. 2008 Aug;58(8):2488-97.PMID: 18668553 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cutaneous vasculitis in breast cancer treated with chemotherapy.

    Wong M, Grossman J, Hahn BH, La Cava A.

    Clin Immunol. 2008 Oct;129(1):3-9. Epub 2008 Jul 21.PMID: 18640073 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity.

    Bai Y, Liu R, Huang D, La Cava A, Tang YY, Iwakura Y, Campagnolo DI, Vollmer TL, Ransohoff RM, Shi FD.

    Eur J Immunol. 2008 Jul;38(7):1877-88.PMID: 18581322 [PubMed - indexed for MEDLINE]Related articles

    22.

    T-regulatory cells in systemic lupus erythematosus.

    La Cava A.

    Lupus. 2008;17(5):421-5. Review.PMID: 18490420 [PubMed - indexed for MEDLINE]Related articles

    23.

    IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.

    Liu R, Bai Y, Vollmer TL, Bai XF, Jee Y, Tang YY, Campagnolo DI, Collins M, Young DA, La Cava A, Shi FD.

    Exp Neurol. 2008 May;211(1):14-24. Epub 2007 Nov 22.PMID: 18353312 [PubMed - indexed for MEDLINE]Related articles

    24.

    Regulatory CD4 T cells: sensing the environment.

    Matarese G, De Rosa V, La Cava A.

    Trends Immunol. 2008 Jan;29(1):12-7. Epub 2007 Dec 3.PMID: 18289503 [PubMed - indexed for MEDLINE]Related articles

    25.

    Autoimmunity and celiac disease.

    Gianfrani C, Troncone R, La Cava A.

    Mini Rev Med Chem. 2008 Feb;8(2):129-34. Review.PMID: 18289095 [PubMed - indexed for MEDLINE]Related articles

    26.

    pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.

    Singh RP, La Cava A, Hahn BH.

    J Immunol. 2008 Feb 15;180(4):2069-80.PMID: 18250412 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis.

    Matarese G, Mantzoros C, La Cava A.

    Curr Pharm Des. 2007;13(36):3676-80. Review.PMID: 18220805 [PubMed - indexed for MEDLINE]Related articles

    28.

    IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis.

    Piao WH, Jee YH, Liu RL, Coons SW, Kala M, Collins M, Young DA, Campagnolo DI, Vollmer TL, Bai XF, La Cava A, Shi FD.

    Scand J Immunol. 2008 Jan;67(1):37-46.PMID: 18052963 [PubMed - indexed for MEDLINE]Related articles

    29.

    Gene vaccination for the induction of immune tolerance.

    Ferrera F, La Cava A, Rizzi M, Hahn BH, Indiveri F, Filaci G.

    Ann N Y Acad Sci. 2007 Sep;1110:99-111. Review.PMID: 17911425 [PubMed - indexed for MEDLINE]Related articles

    30.

    Leptin in autoimmunity: many questions, some answers.

    Matarese G, Leiter EH, La Cava A.

    Tissue Antigens. 2007 Aug;70(2):87-95. Review.PMID: 17610413 [PubMed - indexed for MEDLINE]Related articles

    31.

    CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.

    Singh RP, La Cava A, Wong M, Ebling F, Hahn BH.

    J Immunol. 2007 Jun 15;178(12):7649-57.PMID: 17548601 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.

    Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A.

    Arthritis Rheum. 2007 Jun;56(6):1945-53.PMID: 17530718 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    A key role of leptin in the control of regulatory T cell proliferation.

    De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G.

    Immunity. 2007 Feb;26(2):241-55.PMID: 17307705 [PubMed - indexed for MEDLINE]Related articles

    34.

    ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia.

    Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, Castellani LW, Witztum JL, Lusis AJ, Tsao BP.

    J Lipid Res. 2007 Apr;48(4):794-805. Epub 2007 Jan 26.PMID: 17259598 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    In memoriam: Serafino Zappacosta (1935-2006).

    La Cava A, De Felice M.

    Tissue Antigens. 2006 Oct;68(4):279. No abstract available. PMID: 17026460 [PubMed - indexed for MEDLINE]Related articles

    36.

    Natural and adaptive immune cell-based therapies in autoimmunity.

    La Cava A, Shi FD.

    Curr Med Chem. 2006;13(13):1557-66. Review.PMID: 16787203 [PubMed - indexed for MEDLINE]Related articles

    37.

    CD4+CD25+ Tregs and NKT cells: regulators regulating regulators.

    La Cava A, Van Kaer L, Fu-Dong-Shi.

    Trends Immunol. 2006 Jul;27(7):322-7. Epub 2006 Jun 2. Review.PMID: 16735139 [PubMed - indexed for MEDLINE]Related articles

    38.

    Autoreactive T cells mediate NK cell degeneration in autoimmune disease.

    Liu R, Van Kaer L, La Cava A, Price M, Campagnolo DI, Collins M, Young DA, Vollmer TL, Shi FD.

    J Immunol. 2006 May 1;176(9):5247-54.PMID: 16621990 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis.

    De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, Zappacosta S, Matarese G.

    J Clin Invest. 2006 Feb;116(2):447-55. Epub 2006 Jan 12.PMID: 16410832 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia.

    Liu R, La Cava A, Bai XF, Jee Y, Price M, Campagnolo DI, Christadoss P, Vollmer TL, Van Kaer L, Shi FD.

    J Immunol. 2005 Dec 15;175(12):7898-904.PMID: 16339525 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.

    Hahn BH, Singh RP, La Cava A, Ebling FM.

    J Immunol. 2005 Dec 1;175(11):7728-37.PMID: 16301683 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Manipulation of immune regulation in systemic lupus erythematosus.

    La Cava A, Fang CJ, Singh RP, Ebling F, Hahn BH.

    Autoimmun Rev. 2005 Nov;4(8):515-9. Review.PMID: 16214088 [PubMed - indexed for MEDLINE]Related articles

    43.

    Cellular and molecular mechanisms of regulation of autoantibody production in lupus.

    Hahn BH, Ebling F, Singh RR, Singh RP, Karpouzas G, La Cava A.

    Ann N Y Acad Sci. 2005 Jun;1051:433-41. Review.PMID: 16126985 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.

    Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S.

    Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5150-5. Epub 2005 Mar 23.PMID: 15788534 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.

    Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, Shi FD.

    J Immunol. 2005 Mar 1;174(5):2696-701.PMID: 15728477 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.
    47.

    Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.

    Karpouzas GA, La Cava A, Ebling FM, Singh RR, Hahn BH.

    Eur J Immunol. 2004 Sep;34(9):2489-99.PMID: 15307181 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    The weight of leptin in immunity.

    La Cava A, Matarese G.

    Nat Rev Immunol. 2004 May;4(5):371-9. Review.PMID: 15122202 [PubMed - indexed for MEDLINE]Related articles

    49.

    The intricate interface between immune system and metabolism.

    Matarese G, La Cava A.

    Trends Immunol. 2004 Apr;25(4):193-200. Review.PMID: 15039046 [PubMed - indexed for MEDLINE]Related articles

    50.

    Leptin-based immune intervention: current status and future directions.

    La Cava A, Matarese G, Ebling FM, Hahn BH.

    Curr Opin Investig Drugs. 2003 Nov;4(11):1327-32. Review.PMID: 14758772 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...